

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.43088579 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.06400816 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.64849462 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.35450971 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35450971 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 7.14820708 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.08448427 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 7.08448427 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.91258894 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.91258894 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.91258894 |
| 12 | NADH metabolic process (GO:0006734) | 6.53607858 |
| 13 | tryptophan metabolic process (GO:0006568) | 6.49347251 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.45427146 |
| 15 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.36979505 |
| 16 | glyoxylate metabolic process (GO:0046487) | 6.26688892 |
| 17 | cysteine metabolic process (GO:0006534) | 6.16351914 |
| 18 | lipoprotein transport (GO:0042953) | 6.15948218 |
| 19 | lysine metabolic process (GO:0006553) | 6.12814891 |
| 20 | lysine catabolic process (GO:0006554) | 6.12814891 |
| 21 | regulation of guanylate cyclase activity (GO:0031282) | 5.99073162 |
| 22 | intestinal absorption (GO:0050892) | 5.96230138 |
| 23 | fructose metabolic process (GO:0006000) | 5.74585048 |
| 24 | hormone catabolic process (GO:0042447) | 5.60608834 |
| 25 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.56762520 |
| 26 | bile acid biosynthetic process (GO:0006699) | 5.51914493 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 5.43034845 |
| 28 | urate metabolic process (GO:0046415) | 5.41582428 |
| 29 | drug transmembrane transport (GO:0006855) | 5.37092383 |
| 30 | homocysteine metabolic process (GO:0050667) | 5.21874412 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 5.21498337 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.20181323 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.19610960 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 5.13175576 |
| 35 | plasma lipoprotein particle assembly (GO:0034377) | 5.11675994 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 5.06903365 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.97006093 |
| 38 | urea metabolic process (GO:0019627) | 4.94545516 |
| 39 | urea cycle (GO:0000050) | 4.94545516 |
| 40 | indolalkylamine metabolic process (GO:0006586) | 4.93149613 |
| 41 | cellular biogenic amine catabolic process (GO:0042402) | 4.85819971 |
| 42 | amine catabolic process (GO:0009310) | 4.85819971 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.78391313 |
| 44 | bile acid metabolic process (GO:0008206) | 4.73020058 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.68078908 |
| 46 | drug catabolic process (GO:0042737) | 4.66818251 |
| 47 | diacylglycerol metabolic process (GO:0046339) | 4.65313275 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 4.60042778 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 4.58978925 |
| 50 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.58846510 |
| 51 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.58846510 |
| 52 | endocrine process (GO:0050886) | 4.58846510 |
| 53 | drug transport (GO:0015893) | 4.58675163 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 4.57700500 |
| 55 | protein-lipid complex assembly (GO:0065005) | 4.56299373 |
| 56 | glutamate metabolic process (GO:0006536) | 4.56058713 |
| 57 | tyrosine metabolic process (GO:0006570) | 4.55948589 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.55119703 |
| 59 | protein carboxylation (GO:0018214) | 4.55119703 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 4.50681013 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.47010445 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 4.43464778 |
| 63 | negative regulation of fibrinolysis (GO:0051918) | 4.42874102 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 4.42548551 |
| 65 | complement activation, alternative pathway (GO:0006957) | 4.42167034 |
| 66 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.40928886 |
| 67 | regulation of protein activation cascade (GO:2000257) | 4.36731764 |
| 68 | regulation of fibrinolysis (GO:0051917) | 4.34185250 |
| 69 | alkaloid metabolic process (GO:0009820) | 4.30552489 |
| 70 | aspartate family amino acid catabolic process (GO:0009068) | 4.26736045 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 4.23031949 |
| 72 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.21226031 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.21226031 |
| 74 | cellular glucuronidation (GO:0052695) | 4.18735994 |
| 75 | negative regulation of sterol transport (GO:0032372) | 4.16477576 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 4.16477576 |
| 77 | omega-hydroxylase P450 pathway (GO:0097267) | 4.13015218 |
| 78 | glycine metabolic process (GO:0006544) | 4.12816219 |
| 79 | regulation of cholesterol esterification (GO:0010872) | 4.11551455 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 4.10705934 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 4.09647289 |
| 82 | ethanol metabolic process (GO:0006067) | 4.09198937 |
| 83 | regulation of complement activation (GO:0030449) | 4.07262901 |
| 84 | acylglycerol homeostasis (GO:0055090) | 4.04456896 |
| 85 | triglyceride homeostasis (GO:0070328) | 4.04456896 |
| 86 | ketone body metabolic process (GO:1902224) | 4.03555036 |
| 87 | bile acid and bile salt transport (GO:0015721) | 4.03544447 |
| 88 | regulation of systemic arterial blood pressure (GO:0003073) | 4.03129459 |
| 89 | regulation of triglyceride catabolic process (GO:0010896) | 4.02584980 |
| 90 | lipoprotein metabolic process (GO:0042157) | 4.01384827 |
| 91 | coenzyme catabolic process (GO:0009109) | 4.01103355 |
| 92 | aldehyde catabolic process (GO:0046185) | 4.00791270 |
| 93 | reverse cholesterol transport (GO:0043691) | 3.99603048 |
| 94 | ethanol oxidation (GO:0006069) | 3.98809846 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.96516141 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.95686413 |
| 97 | organic acid catabolic process (GO:0016054) | 3.95686413 |
| 98 | carnitine metabolic process (GO:0009437) | 3.92911243 |
| 99 | protein-lipid complex remodeling (GO:0034368) | 3.91746746 |
| 100 | macromolecular complex remodeling (GO:0034367) | 3.91746746 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 3.91746746 |
| 102 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89055172 |
| 103 | valine metabolic process (GO:0006573) | 3.88966832 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.86825967 |
| 105 | uronic acid metabolic process (GO:0006063) | 3.86825967 |
| 106 | phospholipid efflux (GO:0033700) | 3.84268151 |
| 107 | imidazole-containing compound metabolic process (GO:0052803) | 3.82306757 |
| 108 | peptide catabolic process (GO:0043171) | 3.81359580 |
| 109 | fatty acid oxidation (GO:0019395) | 3.80027340 |
| 110 | fatty acid beta-oxidation (GO:0006635) | 3.79331913 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.79213255 |
| 112 | renal system process involved in regulation of blood volume (GO:0001977) | 3.79025481 |
| 113 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.76017573 |
| 114 | proline metabolic process (GO:0006560) | 3.74106634 |
| 115 | lipid oxidation (GO:0034440) | 3.72771778 |
| 116 | response to mercury ion (GO:0046689) | 3.72746530 |
| 117 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.72109574 |
| 118 | cholesterol efflux (GO:0033344) | 3.70982644 |
| 119 | peptide hormone processing (GO:0016486) | 3.70660524 |
| 120 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67924735 |
| 121 | response to nitrosative stress (GO:0051409) | 3.66592477 |
| 122 | primary alcohol catabolic process (GO:0034310) | 3.66166237 |
| 123 | monocarboxylic acid catabolic process (GO:0072329) | 3.64276159 |
| 124 | virion attachment to host cell (GO:0019062) | 3.62355932 |
| 125 | adhesion of symbiont to host cell (GO:0044650) | 3.62355932 |
| 126 | regulation of cGMP biosynthetic process (GO:0030826) | 3.61902543 |
| 127 | positive regulation of lipid catabolic process (GO:0050996) | 3.61854157 |
| 128 | arginine metabolic process (GO:0006525) | 3.61815228 |
| 129 | indole-containing compound metabolic process (GO:0042430) | 3.59501797 |
| 130 | NAD biosynthetic process (GO:0009435) | 3.59349437 |
| 131 | flavonoid metabolic process (GO:0009812) | 3.58430905 |
| 132 | drinking behavior (GO:0042756) | 3.58378741 |
| 133 | organic cation transport (GO:0015695) | 3.57182497 |
| 134 | protein-lipid complex subunit organization (GO:0071825) | 3.57035871 |
| 135 | branched-chain amino acid metabolic process (GO:0009081) | 3.54083598 |
| 136 | drug metabolic process (GO:0017144) | 3.53961668 |
| 137 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53621964 |
| 138 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53621964 |
| 139 | fatty acid catabolic process (GO:0009062) | 3.53583744 |
| 140 | plasma lipoprotein particle clearance (GO:0034381) | 3.53259602 |
| 141 | digestion (GO:0007586) | 3.47824796 |
| 142 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.46689573 |
| 143 | regulation of cellular extravasation (GO:0002691) | 3.46179977 |
| 144 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.44407569 |
| 145 | vitamin biosynthetic process (GO:0009110) | 3.39821362 |
| 146 | glycolipid catabolic process (GO:0019377) | 3.34854773 |
| 147 | glycosphingolipid catabolic process (GO:0046479) | 3.34647304 |
| 148 | cholesterol homeostasis (GO:0042632) | 3.34061559 |
| 149 | phenylpropanoid metabolic process (GO:0009698) | 3.33715215 |
| 150 | sterol homeostasis (GO:0055092) | 3.28909338 |
| 151 | adhesion of symbiont to host (GO:0044406) | 3.24580987 |
| 152 | fat-soluble vitamin metabolic process (GO:0006775) | 3.24070495 |
| 153 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.23431204 |
| 154 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.23300793 |
| 155 | heme transport (GO:0015886) | 3.15389670 |
| 156 | cellular response to nitric oxide (GO:0071732) | 3.13760567 |
| 157 | axonemal dynein complex assembly (GO:0070286) | 3.05322472 |
| 158 | antibacterial humoral response (GO:0019731) | 3.04044378 |
| 159 | regulation of vitamin metabolic process (GO:0030656) | 3.04002717 |
| 160 | regulation of cholesterol homeostasis (GO:2000188) | 3.03777096 |
| 161 | * vitamin transport (GO:0051180) | 3.02468807 |
| 162 | low-density lipoprotein particle remodeling (GO:0034374) | 3.01729515 |
| 163 | leukotriene metabolic process (GO:0006691) | 3.01121862 |
| 164 | xenobiotic metabolic process (GO:0006805) | 3.00868381 |
| 165 | regulation of cholesterol metabolic process (GO:0090181) | 3.00583963 |
| 166 | sodium ion homeostasis (GO:0055078) | 2.98363232 |
| 167 | phosphate ion transmembrane transport (GO:0035435) | 2.97481605 |
| 168 | proline biosynthetic process (GO:0006561) | 2.96631513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.16665106 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.95785842 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.85710175 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.30992610 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.81540536 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.72378364 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47257203 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.94588294 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85922627 |
| 10 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.26499116 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08553094 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2644122 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.96308848 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96272574 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82763947 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69003588 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68117845 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66430376 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60101749 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57265232 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55319146 |
| 22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.52413842 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39246666 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33333884 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32140997 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28833532 |
| 27 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23518422 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23480237 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23214272 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22580128 |
| 31 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21000184 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19206303 |
| 33 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17373137 |
| 34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15876803 |
| 35 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12936124 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12565959 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12514116 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12188776 |
| 39 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.11181532 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10342494 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10022189 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08676356 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07545816 |
| 44 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07408573 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07297032 |
| 46 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03966985 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02610410 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00668326 |
| 49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00550401 |
| 50 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00269435 |
| 51 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99706029 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97283190 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97249917 |
| 54 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97123586 |
| 55 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97070572 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96663967 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94301199 |
| 58 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93066401 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92525462 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92257403 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91419379 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90815545 |
| 63 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89905009 |
| 64 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89886731 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89658502 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89579309 |
| 67 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.89380346 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88832047 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86929814 |
| 70 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85176789 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85038591 |
| 72 | * P300_27268052_Chip-Seq_Bcells_Human | 0.84732295 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84659893 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.83098330 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82898661 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82431598 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81932257 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81854768 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80408402 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.80360356 |
| 81 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.79546318 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79338213 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79049903 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.78877373 |
| 85 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78846492 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78439384 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78150087 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77540183 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76689119 |
| 90 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76470820 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76258163 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75028368 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72921000 |
| 94 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72503668 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71840308 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70824269 |
| 97 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70582471 |
| 98 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70094551 |
| 99 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69642139 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69508284 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.69063828 |
| 102 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.68721610 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67747769 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67528768 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67528768 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64021664 |
| 107 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63460470 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.62639276 |
| 109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62396042 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60697277 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60617467 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.59896581 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.59177733 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.58645304 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57874427 |
| 116 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.56785104 |
| 117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55619696 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55163552 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54725010 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54143524 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53875942 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.53362397 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53260786 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.52658381 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52209814 |
| 126 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.51626854 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51436077 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50591142 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.50350435 |
| 130 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.50071117 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.50028695 |
| 132 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.49997180 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49630225 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.49546326 |
| 135 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49328355 |
| 136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48368842 |
| 137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47778397 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.47520467 |
| 139 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47010754 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46551573 |
| 141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.46349119 |
| 142 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.44913108 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44182086 |
| 144 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.43243876 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42247964 |
| 146 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.41253271 |
| 147 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.41195662 |
| 148 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.41151407 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.40917050 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40289385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.33055943 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.94506279 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.74384983 |
| 4 | MP0005365_abnormal_bile_salt | 5.62725318 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.07216366 |
| 6 | MP0003252_abnormal_bile_duct | 3.94906338 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.70545799 |
| 8 | MP0003195_calcinosis | 3.61847214 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.60378206 |
| 10 | MP0005332_abnormal_amino_acid | 3.55887383 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.05005427 |
| 12 | * MP0004019_abnormal_vitamin_homeostasis | 2.95720100 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.76328677 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.54391424 |
| 15 | MP0009840_abnormal_foam_cell | 2.50804285 |
| 16 | MP0005083_abnormal_biliary_tract | 2.38924541 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.25011531 |
| 18 | * MP0001666_abnormal_nutrient_absorption | 2.20555705 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.18884231 |
| 20 | * MP0009643_abnormal_urine_homeostasis | 2.06927053 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.92235105 |
| 22 | MP0004043_abnormal_pH_regulation | 1.90010397 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.89514315 |
| 24 | MP0000609_abnormal_liver_physiology | 1.87616964 |
| 25 | MP0005409_darkened_coat_color | 1.82022440 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.78093877 |
| 27 | MP0001764_abnormal_homeostasis | 1.73234649 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.64058593 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60716592 |
| 30 | MP0003868_abnormal_feces_composition | 1.60390850 |
| 31 | MP0005451_abnormal_body_composition | 1.56680769 |
| 32 | MP0003186_abnormal_redox_activity | 1.50879436 |
| 33 | MP0001664_abnormal_digestion | 1.46541153 |
| 34 | MP0001756_abnormal_urination | 1.42002160 |
| 35 | MP0003866_abnormal_defecation | 1.39198706 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.35487264 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.30379894 |
| 38 | MP0000490_abnormal_crypts_of | 1.25149589 |
| 39 | * MP0002136_abnormal_kidney_physiology | 1.19395385 |
| 40 | MP0009697_abnormal_copulation | 1.18117433 |
| 41 | MP0009764_decreased_sensitivity_to | 1.15878006 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.15283148 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.13318234 |
| 44 | MP0000477_abnormal_intestine_morphology | 1.08614794 |
| 45 | MP0003879_abnormal_hair_cell | 1.06873096 |
| 46 | MP0000598_abnormal_liver_morphology | 1.03394643 |
| 47 | MP0005647_abnormal_sex_gland | 1.00106434 |
| 48 | MP0003011_delayed_dark_adaptation | 0.99026149 |
| 49 | MP0005670_abnormal_white_adipose | 0.91651177 |
| 50 | * MP0009642_abnormal_blood_homeostasis | 0.90553225 |
| 51 | MP0002254_reproductive_system_inflammat | 0.90320534 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.90154006 |
| 53 | MP0005408_hypopigmentation | 0.89066446 |
| 54 | MP0008469_abnormal_protein_level | 0.88932398 |
| 55 | MP0002928_abnormal_bile_duct | 0.84332298 |
| 56 | MP0001661_extended_life_span | 0.84328908 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 0.84255078 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.83748331 |
| 59 | MP0009763_increased_sensitivity_to | 0.83409329 |
| 60 | MP0002822_catalepsy | 0.82577536 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 0.81116467 |
| 62 | MP0001188_hyperpigmentation | 0.81105553 |
| 63 | MP0001663_abnormal_digestive_system | 0.79251336 |
| 64 | MP0009115_abnormal_fat_cell | 0.77585548 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.76053054 |
| 66 | MP0005535_abnormal_body_temperature | 0.76009107 |
| 67 | MP0000462_abnormal_digestive_system | 0.75841232 |
| 68 | MP0000604_amyloidosis | 0.75011127 |
| 69 | MP0000538_abnormal_urinary_bladder | 0.73787525 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.72568496 |
| 71 | MP0001873_stomach_inflammation | 0.69506535 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.68948548 |
| 73 | MP0000249_abnormal_blood_vessel | 0.64780420 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.64725287 |
| 75 | MP0009785_altered_susceptibility_to | 0.63739238 |
| 76 | MP0002396_abnormal_hematopoietic_system | 0.62579946 |
| 77 | MP0002168_other_aberrant_phenotype | 0.62036223 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.61426180 |
| 79 | MP0005381_digestive/alimentary_phenotyp | 0.61071198 |
| 80 | MP0010368_abnormal_lymphatic_system | 0.60909892 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.58325495 |
| 82 | MP0004270_analgesia | 0.57918507 |
| 83 | MP0003724_increased_susceptibility_to | 0.57584030 |
| 84 | MP0005334_abnormal_fat_pad | 0.57577244 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.55998493 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.55950795 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.55040131 |
| 88 | MP0002971_abnormal_brown_adipose | 0.54651529 |
| 89 | MP0004858_abnormal_nervous_system | 0.54385763 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.53557856 |
| 91 | MP0005025_abnormal_response_to | 0.52532936 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.51558461 |
| 93 | MP0002135_abnormal_kidney_morphology | 0.51501758 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.51322918 |
| 95 | * MP0005395_other_phenotype | 0.50720767 |
| 96 | MP0001835_abnormal_antigen_presentation | 0.50471833 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.48451989 |
| 98 | MP0009053_abnormal_anal_canal | 0.46391876 |
| 99 | MP0003953_abnormal_hormone_level | 0.45891680 |
| 100 | MP0005266_abnormal_metabolism | 0.45724336 |
| 101 | MP0002796_impaired_skin_barrier | 0.45293038 |
| 102 | MP0003690_abnormal_glial_cell | 0.43725917 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.42238967 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.41963710 |
| 105 | MP0000516_abnormal_urinary_system | 0.41963710 |
| 106 | MP0008260_abnormal_autophagy | 0.41562989 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.39729528 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 0.39665818 |
| 109 | MP0003878_abnormal_ear_physiology | 0.39665818 |
| 110 | * MP0003718_maternal_effect | 0.38034227 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.37327915 |
| 112 | MP0003303_peritoneal_inflammation | 0.37241324 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.36939996 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.36278855 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.36050776 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.35995771 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.34654355 |
| 118 | MP0005448_abnormal_energy_balance | 0.33733935 |
| 119 | MP0003329_amyloid_beta_deposits | 0.33687740 |
| 120 | MP0003436_decreased_susceptibility_to | 0.32153394 |
| 121 | MP0004147_increased_porphyrin_level | 0.31931525 |
| 122 | MP0006082_CNS_inflammation | 0.31582564 |
| 123 | MP0008873_increased_physiological_sensi | 0.31064054 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.30502255 |
| 125 | MP0008874_decreased_physiological_sensi | 0.30080770 |
| 126 | MP0005166_decreased_susceptibility_to | 0.29402474 |
| 127 | MP0003959_abnormal_lean_body | 0.29385762 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.29178598 |
| 129 | MP0008872_abnormal_physiological_respon | 0.29113104 |
| 130 | MP0009672_abnormal_birth_weight | 0.28956393 |
| 131 | MP0002132_abnormal_respiratory_system | 0.27612386 |
| 132 | MP0000566_synostosis | 0.26726304 |
| 133 | MP0000579_abnormal_nail_morphology | 0.26686663 |
| 134 | MP0004381_abnormal_hair_follicle | 0.26378420 |
| 135 | MP0003075_altered_response_to | 0.25959663 |
| 136 | MP0005248_abnormal_Harderian_gland | 0.25691332 |
| 137 | MP0004130_abnormal_muscle_cell | 0.25398413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.42115211 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.02757436 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.51213995 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.49440597 |
| 5 | Xanthomatosis (HP:0000991) | 5.15043195 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.12895361 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.12419912 |
| 8 | Hyperglycinuria (HP:0003108) | 5.12156489 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.93756446 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.67817271 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.67817271 |
| 12 | Hyperglycinemia (HP:0002154) | 4.54612604 |
| 13 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.51867912 |
| 14 | Gout (HP:0001997) | 4.47496267 |
| 15 | Widely patent fontanelles and sutures (HP:0004492) | 4.46540056 |
| 16 | Ketosis (HP:0001946) | 4.45275860 |
| 17 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.43013029 |
| 18 | Hyperammonemia (HP:0001987) | 4.34366834 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27324490 |
| 20 | Joint hemorrhage (HP:0005261) | 4.21523414 |
| 21 | Abnormality of vitamin B metabolism (HP:0004340) | 4.12427247 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 4.12179537 |
| 23 | Chronic diarrhea (HP:0002028) | 4.11643486 |
| 24 | Complement deficiency (HP:0004431) | 4.00542997 |
| 25 | Acanthocytosis (HP:0001927) | 3.94412735 |
| 26 | Abnormality of vitamin metabolism (HP:0100508) | 3.89941274 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.86599513 |
| 28 | Ketoacidosis (HP:0001993) | 3.82004866 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81866306 |
| 30 | Ileus (HP:0002595) | 3.76705016 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.73313902 |
| 32 | Delayed CNS myelination (HP:0002188) | 3.65685596 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.61462885 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.59136998 |
| 35 | Fat malabsorption (HP:0002630) | 3.59021508 |
| 36 | Proximal tubulopathy (HP:0000114) | 3.57733325 |
| 37 | Epidermoid cyst (HP:0200040) | 3.56347219 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.53722816 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48260687 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.46742681 |
| 41 | Alkalosis (HP:0001948) | 3.42757530 |
| 42 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.42724199 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 3.42047117 |
| 44 | Increased purine levels (HP:0004368) | 3.38952995 |
| 45 | Hyperuricemia (HP:0002149) | 3.38952995 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27887909 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.20638800 |
| 48 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.20638800 |
| 49 | Hyperactive renin-angiotensin system (HP:0000841) | 3.16292922 |
| 50 | Vascular calcification (HP:0004934) | 3.13116383 |
| 51 | Hypokalemic alkalosis (HP:0001949) | 3.12775607 |
| 52 | Metabolic acidosis (HP:0001942) | 3.12256509 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 3.09679247 |
| 54 | Generalized aminoaciduria (HP:0002909) | 3.08576231 |
| 55 | Pigmentary retinal degeneration (HP:0001146) | 3.08559529 |
| 56 | Facial shape deformation (HP:0011334) | 3.07886983 |
| 57 | Potter facies (HP:0002009) | 3.07886983 |
| 58 | Wide cranial sutures (HP:0010537) | 3.07547654 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 3.07211503 |
| 60 | Hemorrhage of the eye (HP:0011885) | 3.06182557 |
| 61 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.04441507 |
| 62 | Absent/shortened dynein arms (HP:0200106) | 3.04441507 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.96391552 |
| 64 | Abnormal ciliary motility (HP:0012262) | 2.96303219 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94940556 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.94940556 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.93518657 |
| 68 | Metabolic alkalosis (HP:0200114) | 2.91854494 |
| 69 | Increased circulating renin level (HP:0000848) | 2.90737800 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.89629237 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.88614219 |
| 72 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87616777 |
| 73 | Abnormality of complement system (HP:0005339) | 2.85298025 |
| 74 | Rhinitis (HP:0012384) | 2.83201673 |
| 75 | Lethargy (HP:0001254) | 2.81628348 |
| 76 | Hypophosphatemia (HP:0002148) | 2.80565188 |
| 77 | Megaloblastic anemia (HP:0001889) | 2.80068634 |
| 78 | Thin bony cortex (HP:0002753) | 2.78801591 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 2.76236134 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.74231015 |
| 81 | Hypercholesterolemia (HP:0003124) | 2.73817849 |
| 82 | Abnormal urine phosphate concentration (HP:0012599) | 2.73256907 |
| 83 | Glycosuria (HP:0003076) | 2.72853153 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.72853153 |
| 85 | Hypomagnesemia (HP:0002917) | 2.72762442 |
| 86 | Steatorrhea (HP:0002570) | 2.70576028 |
| 87 | Abnormal urine output (HP:0012590) | 2.69862485 |
| 88 | Malnutrition (HP:0004395) | 2.69085392 |
| 89 | Nasal polyposis (HP:0100582) | 2.65528326 |
| 90 | Enlarged kidneys (HP:0000105) | 2.63247914 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 2.62815187 |
| 92 | Polyuria (HP:0000103) | 2.57132643 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.54080930 |
| 94 | Hydroxyprolinuria (HP:0003080) | 2.54080930 |
| 95 | Vomiting (HP:0002013) | 2.52468838 |
| 96 | Abdominal distention (HP:0003270) | 2.48791751 |
| 97 | Rickets (HP:0002748) | 2.48104636 |
| 98 | Abnormality of renal excretion (HP:0011036) | 2.46668786 |
| 99 | Congenital sensorineural hearing impairment (HP:0008527) | 2.45209043 |
| 100 | Irritability (HP:0000737) | 2.40519448 |
| 101 | Hypotension (HP:0002615) | 2.38027556 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.37277179 |
| 103 | Bronchiectasis (HP:0002110) | 2.36551033 |
| 104 | Cerebral edema (HP:0002181) | 2.30997017 |
| 105 | Abnormality of the nasal mucosa (HP:0000433) | 2.30176158 |
| 106 | Myocardial infarction (HP:0001658) | 2.29784936 |
| 107 | Abnormality of magnesium homeostasis (HP:0004921) | 2.26721466 |
| 108 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26567474 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.23364358 |
| 110 | Renal tubular acidosis (HP:0001947) | 2.22879846 |
| 111 | Nephritis (HP:0000123) | 2.20394025 |
| 112 | Neonatal onset (HP:0003623) | 2.20187476 |
| 113 | Confusion (HP:0001289) | 2.19103278 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.18903072 |
| 115 | Hypochromic microcytic anemia (HP:0004840) | 2.18664294 |
| 116 | Posterior subcapsular cataract (HP:0007787) | 2.17647777 |
| 117 | Nephrolithiasis (HP:0000787) | 2.17072816 |
| 118 | Spastic diplegia (HP:0001264) | 2.16401418 |
| 119 | Pancreatitis (HP:0001733) | 2.14870945 |
| 120 | Renal cortical cysts (HP:0000803) | 2.14264708 |
| 121 | Glomerulonephritis (HP:0000099) | 2.13383932 |
| 122 | Spontaneous abortion (HP:0005268) | 2.11631338 |
| 123 | Mitral stenosis (HP:0001718) | 2.11002692 |
| 124 | Hypophosphatemic rickets (HP:0004912) | 2.09942030 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.09625095 |
| 126 | Late onset (HP:0003584) | 2.09106330 |
| 127 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.07520609 |
| 128 | Villous atrophy (HP:0011473) | 2.07520609 |
| 129 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07188002 |
| 130 | Chronic bronchitis (HP:0004469) | 2.06414973 |
| 131 | Tetany (HP:0001281) | 2.04763645 |
| 132 | Hyperphosphaturia (HP:0003109) | 2.04524478 |
| 133 | Poikilocytosis (HP:0004447) | 2.02183052 |
| 134 | Enlarged epiphyses (HP:0010580) | 2.01410501 |
| 135 | Delayed epiphyseal ossification (HP:0002663) | 1.99786794 |
| 136 | Opisthotonus (HP:0002179) | 1.99652448 |
| 137 | Recurrent sinusitis (HP:0011108) | 1.99540494 |
| 138 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98001747 |
| 139 | Abnormal glucose tolerance (HP:0001952) | 1.97205968 |
| 140 | Renal salt wasting (HP:0000127) | 1.95434194 |
| 141 | Skin nodule (HP:0200036) | 1.94900831 |
| 142 | Nausea (HP:0002018) | 1.94063856 |
| 143 | Hyperaldosteronism (HP:0000859) | 1.93120607 |
| 144 | Protuberant abdomen (HP:0001538) | 1.87856128 |
| 145 | Abnormality of the costochondral junction (HP:0000919) | 1.85440948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.54110253 |
| 2 | BCKDK | 6.30024559 |
| 3 | WNK3 | 5.69460708 |
| 4 | OXSR1 | 3.96540948 |
| 5 | WNK4 | 3.95216967 |
| 6 | FGFR4 | 3.67886573 |
| 7 | SIK1 | 2.96969625 |
| 8 | INSRR | 2.90263909 |
| 9 | ERN1 | 2.90102263 |
| 10 | PRKG2 | 2.85099883 |
| 11 | STK38L | 2.51790274 |
| 12 | MAP3K10 | 2.43800994 |
| 13 | TAOK3 | 2.39999526 |
| 14 | MAP3K2 | 2.37077666 |
| 15 | MST4 | 2.11419768 |
| 16 | MST1R | 2.01701749 |
| 17 | ERBB4 | 1.96006079 |
| 18 | IRAK3 | 1.78707620 |
| 19 | TESK2 | 1.78187144 |
| 20 | MAP3K14 | 1.66078051 |
| 21 | LATS1 | 1.64766509 |
| 22 | PINK1 | 1.61008906 |
| 23 | PIK3CG | 1.56898242 |
| 24 | SGK494 | 1.48386983 |
| 25 | SGK223 | 1.48386983 |
| 26 | MAPK11 | 1.47207304 |
| 27 | MAP4K1 | 1.46238710 |
| 28 | RIPK4 | 1.45347721 |
| 29 | SGK2 | 1.40727587 |
| 30 | FRK | 1.40475702 |
| 31 | EPHA4 | 1.33819356 |
| 32 | SGK3 | 1.28941712 |
| 33 | TYK2 | 1.25182087 |
| 34 | MAP2K4 | 1.21253640 |
| 35 | MATK | 1.15935030 |
| 36 | TIE1 | 1.14490217 |
| 37 | ABL2 | 1.12903000 |
| 38 | STK39 | 1.12808901 |
| 39 | MAP3K3 | 1.12142986 |
| 40 | NEK9 | 1.10023890 |
| 41 | FLT3 | 1.07986769 |
| 42 | PRKAA2 | 1.04968585 |
| 43 | STK24 | 1.01903857 |
| 44 | PIK3CA | 1.01378901 |
| 45 | MAP3K7 | 1.00918461 |
| 46 | GRK6 | 1.00843312 |
| 47 | MAP3K1 | 0.97862253 |
| 48 | DDR2 | 0.95798439 |
| 49 | MAPK15 | 0.95317336 |
| 50 | SMG1 | 0.92055843 |
| 51 | MAP2K3 | 0.91512020 |
| 52 | MAP2K2 | 0.91266257 |
| 53 | TRIB3 | 0.88527484 |
| 54 | PTK6 | 0.86824612 |
| 55 | TGFBR2 | 0.83701190 |
| 56 | CDC42BPA | 0.83649491 |
| 57 | PRPF4B | 0.81415902 |
| 58 | JAK2 | 0.81311327 |
| 59 | PDK1 | 0.81303291 |
| 60 | MAP3K12 | 0.80952980 |
| 61 | PRKAA1 | 0.79866977 |
| 62 | STK16 | 0.79308848 |
| 63 | EEF2K | 0.76995444 |
| 64 | GSK3A | 0.76455399 |
| 65 | IRAK1 | 0.76337782 |
| 66 | PDK3 | 0.75830864 |
| 67 | PDK4 | 0.75830864 |
| 68 | IRAK2 | 0.74957242 |
| 69 | DAPK2 | 0.72915952 |
| 70 | PRKCZ | 0.72530019 |
| 71 | KDR | 0.72147160 |
| 72 | GRK1 | 0.71272740 |
| 73 | EPHB1 | 0.71003989 |
| 74 | PDK2 | 0.70169898 |
| 75 | ZAK | 0.69699211 |
| 76 | ERBB2 | 0.64849003 |
| 77 | DYRK1B | 0.64691376 |
| 78 | TNIK | 0.64334457 |
| 79 | JAK1 | 0.63400785 |
| 80 | FGFR2 | 0.62632445 |
| 81 | STK38 | 0.61685102 |
| 82 | IKBKE | 0.61047599 |
| 83 | NEK6 | 0.59442612 |
| 84 | RET | 0.58779444 |
| 85 | MAPK4 | 0.57012287 |
| 86 | MAP2K6 | 0.56575961 |
| 87 | TBK1 | 0.56462324 |
| 88 | PRKACG | 0.56381529 |
| 89 | CSK | 0.56015217 |
| 90 | AKT3 | 0.54878104 |
| 91 | FER | 0.54037694 |
| 92 | NUAK1 | 0.53697565 |
| 93 | MAPKAPK3 | 0.51294263 |
| 94 | MAP3K11 | 0.50323572 |
| 95 | EPHB2 | 0.48920235 |
| 96 | TESK1 | 0.48556782 |
| 97 | CSF1R | 0.48351397 |
| 98 | PIM1 | 0.47858420 |
| 99 | TAOK2 | 0.47544940 |
| 100 | ICK | 0.46109395 |
| 101 | MET | 0.46049758 |
| 102 | TAOK1 | 0.45918421 |
| 103 | SRC | 0.45831128 |
| 104 | PTK2 | 0.44074313 |
| 105 | LMTK2 | 0.43596019 |
| 106 | MAPK12 | 0.43147054 |
| 107 | PRKCQ | 0.41430687 |
| 108 | YES1 | 0.39436729 |
| 109 | NME1 | 0.39295989 |
| 110 | KSR2 | 0.39243695 |
| 111 | FYN | 0.38277629 |
| 112 | PDPK1 | 0.37508617 |
| 113 | CAMK2G | 0.37141215 |
| 114 | MAPK7 | 0.36968717 |
| 115 | PRKCI | 0.35520672 |
| 116 | EPHA3 | 0.35322689 |
| 117 | ZAP70 | 0.35171184 |
| 118 | PKN2 | 0.34264818 |
| 119 | LYN | 0.34170006 |
| 120 | SYK | 0.33546648 |
| 121 | MELK | 0.33177671 |
| 122 | NEK1 | 0.33140415 |
| 123 | PBK | 0.32544702 |
| 124 | IGF1R | 0.32153411 |
| 125 | CDK6 | 0.31588808 |
| 126 | CHUK | 0.29657745 |
| 127 | FGFR3 | 0.29618191 |
| 128 | PRKACA | 0.29322936 |
| 129 | TEC | 0.28760625 |
| 130 | MYLK | 0.28699820 |
| 131 | SGK1 | 0.28280090 |
| 132 | LRRK2 | 0.28245310 |
| 133 | PRKCA | 0.27663151 |
| 134 | LCK | 0.27580458 |
| 135 | NLK | 0.26204244 |
| 136 | RIPK1 | 0.26028253 |
| 137 | BLK | 0.25819415 |
| 138 | PRKCD | 0.24799717 |
| 139 | BMPR2 | 0.24725640 |
| 140 | MAP3K5 | 0.23179668 |
| 141 | CSNK1G1 | 0.22864814 |
| 142 | IRAK4 | 0.22138899 |
| 143 | ITK | 0.22068266 |
| 144 | CDK9 | 0.21881077 |
| 145 | PKN1 | 0.21800017 |
| 146 | WNK1 | 0.21167764 |
| 147 | EPHA2 | 0.19466072 |
| 148 | MAP3K6 | 0.18636716 |
| 149 | BTK | 0.18584841 |
| 150 | CAMK4 | 0.18543014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.85436408 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45646223 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89278048 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87776160 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84314804 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.82129293 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69113920 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69082638 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56395299 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54257749 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54111619 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51905979 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49762611 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.37231997 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27350457 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20221629 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11737345 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10971468 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95645283 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95505587 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89021771 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87531759 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86521156 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84587911 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.81929204 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81841380 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78121960 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.77692949 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64223144 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62452787 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.61046427 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59922061 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56385888 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55555374 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49944377 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47855562 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45843894 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39341939 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38192692 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34752654 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34532979 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30438115 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28630254 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23947792 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23243671 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21282187 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20441369 |
| 48 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19188498 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.14013587 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.13678455 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13070700 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12812729 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12524497 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11341499 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 1.05688259 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03410062 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94983581 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92003791 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91752748 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82861093 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77520810 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76035202 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75617925 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73084516 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72795699 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70652253 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67240140 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.65425428 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54569485 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54303454 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.46876665 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41632834 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39475679 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37866165 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26687436 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.26568388 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26525477 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25952528 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25587505 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24830483 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23267317 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17081024 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14611716 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.12939574 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12308545 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.12307611 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11613384 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11079321 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09003655 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08231619 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.08186145 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08174674 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.06983644 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.06906443 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06847043 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.06309874 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05029089 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.04400250 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.00871498 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00567230 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2373034 |
| 102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.2363796 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2129018 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2011155 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1819194 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1391296 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1332892 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.1238762 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | -0.1153741 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0856758 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0700486 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0641922 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0572165 |
| 114 | Lysosome_Homo sapiens_hsa04142 | -0.0507998 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0479747 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0352424 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0305927 |
| 118 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0190246 |
| 119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0090577 |

